CBI's Forum on Global Pricing and Market Access Strategies

Jan. 21, 2010-Jan. 22, 2010
The Loews Hotel
Philadelphia, PA
www.cbinet.com/show_conference.cfm?confCode=PC10017&field=summary

Description:

CBI's Forum on Global Pricing and Market Access Strategies

Lujing Wang, Vice President, Managed Markets Practice, will present a session on evidence-based medicine in an evolving landscape for global market access.

Abstract:

Evidence-Based Medicine in an Evolving Landscape for Global Market Access

The global landscape for market access is evolving and there are major trends taking hold that are reshaping the way payers and reimbursement bodies make reimbursement and coverage decisions. In order to survive in this evolving environment, pharmaceutical companies must re-evaluate their current approach to access decision making and begin thinking more strategically about evidence-based medicine and how to address market access challenges.

  • Examine the major trends that are shaping the global market access landscape
  • Learn the key market access barriers and how they vary by geographic market and disease area
  • Increase focus on evidence based medicine and HTA
  • The evolving requirement for evidence to support product reimbursement and access
  • Understand how trends are shaping pharmaceutical markets
  • Implications for pharmaceutical companies:

o      Overcome the growing sophistication of payers which forces companies to think more strategically about how to address market access challenges

o       Better integrate evidence generation and value substantiation into the commercial planning process

 

View Entire Event Calendar

Don't Miss